Archived from the original on June 14, 2023
No significant differences in CD8 + and CD4 + T cell and B220 + B cell numbers were observed between obese PAR2-G37I and WT mice (Supplemental Figure 5J)
We liked the affordability (around 15p per day) and straightforward formulation
For all clinical questions, please consult your medical provider.
This science-backed method revolves around activating key arousal pathways with an FDA-approved peptide: PT-141 (bremelanotide), commonly known as the "Pink Shot." It addresses hypoactive sexual desire disorder (HSDD) by stimulating brain receptors involved in sexual motivation, leading to increased desire, better lubrication, heightened sensitivity, reduced pain during intercourse, and greater overall satisfactionwithout directly altering hormones.[1][2][3] Clinical trials show it can significantly improve sexual function scores in premenopausal women with HSDD, with up to 51% reporting enhanced desire compared to placebo groups, but its benefits extend to perimenopausal and postmenopausal women dealing with vaginal atrophy and low libido.[1] Weve long known that peptides can influence sexual health, but PT-141 stands out as the first FDA-approved injectable specifically for HSDD in women
NIH describes the cardiovascular implications as uncertain but concerning enough to discuss with a clinician if you have heart disease risk, high LDL cholesterol, kidney disease, or plan to use high doses for months
